Clinical Trial

Copper to Zinc Ratio in End Stage Renal Disease Patients Outcome

Name: Copper to Zinc Ratio in End Stage Renal Disease Patients Outcome — clinical trial record (NCT07109778)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Record status

This record was last updated August 7, 2025 (before its estimated February 1, 2026 completion). Its status may not reflect the trial's current state.

Summary

The goal of this observational clinical trial is to Study the impact of copper to zinc ratio on the outcome of ESRD patients

Trial Details

NCT Number	NCT07109778
Lead Sponsor	Minia University
Conditions	ESRD (End Stage Renal Disease), Control Condition
Enrollment	150 participants
Start Date	2025-08-01
Primary Completion	2026-02-01 (estimated)
Study Completion	2026-04-01 (estimated)
Updated on ClinicalTrials.gov	2025-08-07